Pfizer Inc. (PFE): Price and Financial Metrics

Pfizer Inc. (PFE): $50.73

-0.18 (-0.35%)

POWR Rating

Component Grades














  • PFE scores best on the Value dimension, with a Value rank ahead of 96.13% of US stocks.
  • PFE's strongest trending metric is Value; it's been moving up over the last 177 days.
  • PFE's current lowest rank is in the Momentum metric (where it is better than 12.41% of US stocks).

PFE Stock Summary

  • PFIZER INC's market capitalization of $284,763,446,462 is ahead of 99.54% of US-listed equities.
  • PFE's went public 36.95 years ago, making it older than 93.49% of listed US stocks we're tracking.
  • The volatility of PFIZER INC's share price is greater than that of only 10.01% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to PFIZER INC, a group of peers worth examining would be MRK, ABBV, NVO, LLY, and BABA.
  • PFE's SEC filings can be seen here. And to visit PFIZER INC's official web site, go to

PFE Valuation Summary

  • In comparison to the median Healthcare stock, PFE's price/sales ratio is 45% higher, now standing at 2.9.
  • Over the past 243 months, PFE's price/earnings ratio has gone down 12.7.

Below are key valuation metrics over time for PFE.

Stock Date P/S P/B P/E EV/EBIT
PFE 2022-12-01 2.9 3.1 9.6 9.7
PFE 2022-11-30 2.8 3.0 9.5 9.5
PFE 2022-11-29 2.8 3.0 9.3 9.4
PFE 2022-11-28 2.8 3.0 9.3 9.4
PFE 2022-11-25 2.8 3.0 9.3 9.4
PFE 2022-11-23 2.8 3.0 9.2 9.3

PFE Growth Metrics

    Its 3 year net cashflow from operations growth rate is now at 122.51%.
  • Its 3 year cash and equivalents growth rate is now at 27.52%.
  • Its 4 year revenue growth rate is now at -4.1%.
Over the past 70 months, PFE's revenue has gone up $46,852,000,000.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 99,676 26,599 29,771
2022-06-30 101,132 31,454 29,309
2022-03-31 92,367 34,583 24,966
2021-12-31 81,288 32,580 21,979
2021-09-30 63,600 32,291 19,180
2021-06-30 51,637 23,552 13,228

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
  • PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
  • XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.312 0.704 0.149
2021-04-04 0.265 0.763 0.116
2020-12-31 0.247 0.793 0.099
2020-09-27 0.282 0.799 0.083
2020-06-28 0.288 0.799 0.181
2020-03-29 0.307 0.799 0.200

PFE Price Target

For more insight on analysts targets of PFE, see our PFE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $46.03 Average Broker Recommendation 1.8 (Hold)

PFE Stock Price Chart Interactive Chart >

Price chart for PFE

PFE Price/Volume Stats

Current price $50.73 52-week high $61.71
Prev. close $50.91 52-week low $41.44
Day low $50.35 Volume 17,959,700
Day high $51.03 Avg. volume 24,548,988
50-day MA $46.20 Dividend yield 3.14%
200-day MA $49.09 Market Cap 284.76B

Pfizer Inc. (PFE) Company Bio

Pfizer Inc. is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. Pfizer was founded under its original name, Charles Pfizer & Company, in 1849 in Brooklyn, New York by Charles Pfizer and Charles Erhart. The company operates research and development facilities in United States and the United Kingdom and employs over 78,000 individuals worldwide. Some of the company’s more recognizable brands include Advil, Celebrex, Chantix, Chapstick, Dimetapp, Lipitor, Robitussin, and Viagra. Albert Bourla serves as Pfizer’s Chairman of the Board and Chief Executive Officer and the company is headquartered in New York, New York.

PFE Latest News Stream

Event/Time News Detail
Loading, please wait...

PFE Latest Social Stream

Loading social stream, please wait...

View Full PFE Social Stream

Latest PFE News From Around the Web

Below are the latest news stories about PFIZER INC that investors may wish to consider to help them evaluate PFE as an investment opportunity.

7 Most Undervalued Stocks to Buy Now

Trust these undervalued stocks to bolster a portfolio once the market reaches a firm bottom and reverses higher for good.

Joel Baglole on InvestorPlace | November 30, 2022

7 Undervalued Biotech Stocks to Buy Before They Boom

Speculative investors should consider building a position in these undervalued biotech stocks before the market rebounds.

Josh Enomoto on InvestorPlace | November 30, 2022

7 Seriously Undervalued Dividend Stocks to Buy for High Total Returns

These undervalued quality dividend stocks provide a robust yield and also look poised for a breakout on the upside in the future.

Faisal Humayun on InvestorPlace | November 30, 2022

13 Best Biotech Penny Stocks To Buy Now

In this article, we will be taking a look at the 13 best biotech penny stocks to buy now. To skip our detailed analysis of these stocks, you can go directly to see the 5 Best Biotech Penny Stocks To Buy Now. Biotechnology is a sector that has long been contributing to the improvement of […]

Yahoo | November 29, 2022

At All-Time Highs, Merck's Stock Is Nearing a Cliff

The pharmaceutical giant faces a future drop-off in its Covid-19 drug and patent expirations

Yahoo | November 29, 2022

Read More 'PFE' Stories Here

PFE Price Returns

1-mo 7.43%
3-mo 10.91%
6-mo -0.42%
1-year 1.74%
3-year 56.18%
5-year 80.95%
YTD -11.30%
2021 66.70%
2020 3.23%
2019 -6.91%
2018 24.82%
2017 15.90%

PFE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6618 seconds.